Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05091567 |
|---|---|
| Brief Title: | A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer (IMforte) |
| First Submitted : | October 12, 2021 |
| First Submitted that Met QC Criteria : | October 12, 2021 |
| First Posted : | October 25, 2021 |
| Last Update Submitted that Met QC Criteria : | March 10, 2024 |
| Last Update Posted : | March 12, 2024 |